ProShare Advisors
NNVC icon

ProShare Advisors’s NanoViricides NNVC Stock Holding History

ProShare Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-797
Closed -$48K – 2070
2014
Q3 		$48K Sell
797
-180
-18% -$14.1K ﹤0.01% 2268
2014
Q2 		$83K Buy
+977
New +$69.3K ﹤0.01% 2395

Other funds holding NNVC

BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TIAA CREF Investment Management
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

ProShare Advisors's NNVC Position: Q4 2014 in Review

ProShare Advisors sold out of NanoViricides (NNVC) in Q4 2014, closing a stake of 797 shares — an estimated $48K sold.

ProShare Advisors first reported a position in NNVC in Q2 2014 and held it in 2 quarters. The position peaked at $83K in Q2 2014. 54 funds tracked by Wall St. Rank hold NNVC as of Q4 2014.

  • ProShare Advisors reported no remaining NanoViricides position as of Q4 2014 after selling out during the quarter.
  • ProShare Advisors sold 797 NanoViricides shares in Q4 2014, an estimated $48K.
  • ProShare Advisors first reported a position in NanoViricides in Q2 2014 and held it in 2 quarters.
  • ProShare Advisors's NanoViricides position peaked at $83K in Q2 2014.
  • 54 funds tracked by Wall St. Rank held NanoViricides as of Q4 2014.

Based on ProShare Advisors's 13F filing for Q4 2014, filed 30 Jan 2015.